Sodium Bicarbonate 10 Gr. (650 Mg) Tablet
NDC Package 77333-829-10
Package Information
Sodium Bicarbonate 10 Gr. (650 Mg) (sodium bicarbonate) tablets is do not use the maximum dosage for more than 2 weekstablets may be swallowed whole or dissolved in water prior to useadults 60 years of age and over: 1-2 tablets every 4 hours, not more than 12 tablets in 24 hoursadults under 60 years of age: 1-4 tablets every 4 hours, not more than 24 tablets in 24 hours. This formulation utilizes a tablet delivery system. Marketed by Gendose Pharmaceuticals, Llc, this product is identified by NDC 77333-829 and is authorized under FDA application M001.
Identification & Billing
- RxCUI: 198861 - sodium bicarbonate 650 MG Oral Tablet
- RxCUI: 198861 - NaHCO3 650 MG Oral Tablet
- RxCUI: 198861 - sodium bicarbonate 10 Grains Oral Tablet
- RxCUI: 198861 - sodium bicarbonate 648 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 77333 - Gendose Pharmaceuticals, Llc
- 77333-829 - Sodium Bicarbonate 10 Gr. (650 Mg)
- 77333-829-10 - 100 BLISTER PACK in 1 BOX, UNIT-DOSE / 10 TABLET in 1 BLISTER PACK (77333-829-25)
- 77333-829 - Sodium Bicarbonate 10 Gr. (650 Mg)
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 77333-829-10 identifies a specific commercial package of 100 blister pack in 1 box, unit-dose / 10 tablet in 1 blister pack (77333-829-25) of Sodium Bicarbonate 10 Gr. (650 Mg), a human over the counter drug labeled by Gendose Pharmaceuticals, Llc. This tablet is formulated for oral use and contains sodium bicarbonate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Gendose Pharmaceuticals, Llc on May 01, 2026. The current certification is valid through December 31, 2027.
How is this Gendose Pharmaceuticals, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 77333082910. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.